EP 51 20-year study of 55,000 Canadians: Alberta's Tomorrow Project with Dr Jennifer Vena

November 26th, 2020  |  48 mins 10 secs

Patrick and Jennifer discuss the history of the Alberta's Tomorrow Project, its goals for the future, and the role Covid will continue to play including with research studies that are not directly associated with the disease.

EP 50 Dr Barry Singer, the MS doctor who is using technology to connect with patients and scale his impact

November 11th, 2020  |  45 mins 31 secs

Dr Barry Singer is a neurologist who specialises in multiple sclerosis, he is also the host of MS Living Well, a podcast that deals with living with multiple sclerosis. In 2007 Dr Singer created the website MS living well as a resource centre for patients looking to find information about the disease.

EP 49 Genomics in education and the social sciences with Dr Daphne Martschenko

October 29th, 2020  |  45 mins 29 secs

Patrick and Dr Daphne Martschenko discuss the history of IQ testing, how genome-wide association analysis and polygenic risk scores are being applied to education, and the ethical issues surrounding gene editing technologies.

EP 48 Tipping the Balance on Ulcerative Colitis with Seb Tucknott

October 14th, 2020  |  51 mins 2 secs

Seb Tucknott is an author and patient advocate who was diagnosed with Ulcerative Colitis in 2008. Seb joins the podcast to discuss how to view the healthcare system from an outsider's perspective, making lifestyle changes, and his 2019 book 'Tipping the Balance'.

EP 47 HDR-UK CEO Caroline Cake: Making the UK a world leader in health data science

September 30th, 2020  |  40 mins 30 secs

Chief Executive Officer of Health Data Research UK Caroline Cake joins Patrick to talk about accelerating medical research through health data science

EP 46 Rebel Cell: Kat Arney's new book on Cancer, Evolution, and the Science of Life

September 16th, 2020  |  38 mins 4 secs

book, cancer, kat arney, rebel cell

Kat Arney returns to the podcast to discuss her new book ‘Rebel Cell’, which takes an evolutionary look at cancer.

EP 45 Steff Di Pardo on Ankylosing Spondylitis and Instagram as a support network for health communities

September 2nd, 2020  |  23 mins 22 secs

ankylosing spondylitis, chronic health, health

This week we talk to Steff Di Pardo, a patient advocate and writer who has Ankylosing Spondylitis - which is a chronic autoimmune disease. She talks about the long road to diagnosis, how she started opening up about her condition to friends and family on Facebook, and her decision to bring her refreshing honesty to a wider audience with her blog, Totally Chronic.

EP 44 Bringing preventive health to 8 billion people: Peter Würtz from Nightingale Health on their pioneering blood testing platform

August 19th, 2020  |  39 mins 28 secs

We talk to Peter about their work with the UK Biobank, including recent research that shows their blood test could be used predict severe COVID19 well before onset of symptoms.

EP 43 Diversity in clinical research and COVID19's impact on people with immune conditions with Dr Sonya Abraham.

August 5th, 2020  |  43 mins 23 secs

Sonya Abraham is a clinical senior lecturer in rheumatology and a research physician at Imperial College London. We talk to her about BAME representation in clinical research and about her rheumatology research, including the role of the microbiome, and what COVID19 researchers can learn from existing rheumatology research.

EP 42 Tapoka Mkandawire on the gut microbiome, neglected tropical diseases, and the power of citizen science

July 29th, 2020  |  33 mins 51 secs

Tapoka Mkandawire is a PhD student in parasitology & genomics at the Wellcome Sanger Institute. She studies neglected tropical diseases, which affect hundreds of millions of people worldwide but aren't that well known in the UK.

EP 41 Keith McArthur, the rare disease dad who is re-writing the rules in order to find a cure for his son - Live Podcast

July 25th, 2020  |  50 mins 27 secs

genetics, grin, patients, rare disease, research

Keith McArthur is one of the parents re-writing the rules for research in rare disease. Keith is CEO of the CureGRIN foundation, a non-profit backed by the Chan-Zuckerberg Initiative. Keith and his co-founder Denise Rehner believe that patients hold the power to accelerate research and drive progress, and that a cure for GRIN Disorders is possible.

EP 40 Professor Sir Rory Collins on the origins and future of the UKBiobank

July 23rd, 2020  |  34 mins 58 secs

biobank, coronavirus, covid, covid19, genetics, medical research, medicine, research

Professor Sir Rory Collins, Founder and Chief Executive of the UK Biobank, talks to us this week about the origins of this world-changing project that has catalysed a wave of new discoveries in large part by levelling playing field in data access.

Ep 39 How hundreds of scientists from 50 nations are collaborating on Slack to study genetics & COVID19 with Dr Andrea Ganna

July 9th, 2020  |  41 mins 56 secs

covid, covid 19, genetics, research, researchers, virus

Andrea Ganna has been leading COVID19HG, a worldwide effort to understand the role that our genetics plays in COVID-19 infection and severity. In this episode, we discuss some of the group's findings so far and the origins of this initiative, which has now attracted hundreds of researchers from over 50 nations.

Ep 38 Big Data in genomics - why we need 'the cloud' and AI to make sense of it all with Dr Maria Chatzou Dunford

June 30th, 2020  |  38 mins 45 secs

ai, big data, data, genetics, lifebit, maria chatzou dunford, the cloud

Genomic data, is big data - so how do we actually make sense of this huge amount of data? And why should we use 'the cloud’ to store and analyse it? We talk to Dr Maria Chatzou Dunford, CEO and Co-Founder of LifeBit, a company that wants to democratise analysis of genetic big data.

EP 37 The future of medical research post COVID

June 10th, 2020  |  44 mins 21 secs

coronavirus, covid, covid19, medical research, medicine, research

This week, we look at some of the dramatic changes in the field of medical research as a result of COVID19 making it unsafe for people to visit medical research facilities, and medical professional's time and efforts being redirected to fighting the new virus.

EP 36 Genomics England CEO Chris Wigley & Clinical Lead Richard Scott: sequencing 35,000 people with COVID19, the future of genomic medicine, and why patients are their 'north star'

May 27th, 2020  |  25 mins 18 secs

coronavirus, covid19, genetics, genomics england

Why do some people have a severe response to COVID-19, and others seem to have no symptoms at all? Is the answer in our genes?

This week we talk to Chris Wigley, the CEO of Genomics England and Interim SRO for Data-NHSX, and Dr Richard Scott, the clinical lead for rare disease at Genomics England and consultant clinical geneticist at Great Ormond Street.

If you would like to volunteer for Genomics England's study on COVID19, sign up here: https://www.genomicsengland.co.uk/covid-19/